Kevan C Herold

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 62

Top Venues

Diabetes care

Nature reviews. Immunology

Diabetes

Science translational medicine

Yale University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Yale University Aug 01 2007

United States

Professor :: Immunobiology

Publications

Michael J Haller, David Cuthbertson, Brian N Bundy, Mark A Atkinson, Wayne Moore, Michael J Haller, William E Russell, Stephen E Gitelman, Kevan C Herold, Maria J Redondo, Emily K Sims, Diane K Wherrett, Antoinette Moran, Alberto Pugliese, Peter A Gottlieb, Jay M Sosenko, Heba M Ismail, null null
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials. Diabetes care 47 (6) (2024)
Michael J Haller, David Cuthbertson, Brian N Bundy, Mark A Atkinson, Wayne Moore, Michael J Haller, William E Russell, Stephen E Gitelman, Kevan C Herold, Maria J Redondo, Emily K Sims, Diane K Wherrett, Antoinette Moran, Alberto Pugliese, Peter A Gottlieb, Jay M Sosenko, Heba M Ismail, null null
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials. Diabetes care 47 (6) (2024)
Lucienne Chatenoud, Kevan C Herold, Jean-François Bach, Jeffrey A Bluestone
The Teplizumab Saga: The Challenge of Not Getting Lost in Clinical Translation. Cold Spring Harbor perspectives in medicine (2024)
Kevan C Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M Brusko, Lucy Sarah Kate Walker
The immunology of type 1 diabetes. Nature reviews. Immunology 24 (6) (2024)
Kevan C Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M Brusko, Lucy Sarah Kate Walker
The immunology of type 1 diabetes. Nature reviews. Immunology 24 (6) (2024)
Michael J Haller, David Cuthbertson, Brian N Bundy, Mark A Atkinson, Wayne Moore, Michael J Haller, William E Russell, Stephen E Gitelman, Kevan C Herold, Maria J Redondo, Emily K Sims, Diane K Wherrett, Antoinette Moran, Alberto Pugliese, Peter A Gottlieb, Jay M Sosenko, Heba M Ismail, null null
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials. Diabetes care 47 (6) (2024)
Kevan C Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M Brusko, Lucy Sarah Kate Walker
The immunology of type 1 diabetes. Nature reviews. Immunology 24 (6) (2024)
Kevan C Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M Brusko, Lucy Sarah Kate Walker
The immunology of type 1 diabetes. Nature reviews. Immunology 24 (6) (2024)
Kevan C Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M Brusko, Lucy Sarah Kate Walker
The immunology of type 1 diabetes. Nature reviews. Immunology 24 (6) (2024)
Kevan C Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M Brusko, Lucy Sarah Kate Walker
The immunology of type 1 diabetes. Nature reviews. Immunology (2024)
Kevan C Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M Brusko, Lucy Sarah Kate Walker
The immunology of type 1 diabetes. Nature reviews. Immunology (2024)
Kevan C Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M Brusko, Lucy Sarah Kate Walker
The immunology of type 1 diabetes. Nature reviews. Immunology (2024)
Kevan C Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M Brusko, Lucy Sarah Kate Walker
The immunology of type 1 diabetes. Nature reviews. Immunology (2024)
Kevan C Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M Brusko, Lucy Sarah Kate Walker
The immunology of type 1 diabetes. Nature reviews. Immunology 24 (6) (2024)
Kevan C Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M Brusko, Lucy Sarah Kate Walker
The immunology of type 1 diabetes. Nature reviews. Immunology (2024)
Michael J Haller, David Cuthbertson, Brian N Bundy, Mark A Atkinson, Wayne Moore, Michael J Haller, William E Russell, Stephen E Gitelman, Kevan C Herold, Maria J Redondo, Emily K Sims, Diane K Wherrett, Antoinette Moran, Alberto Pugliese, Peter A Gottlieb, Jay M Sosenko, Heba M Ismail, null null
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials. Diabetes care 47 (6) (2024)
Esther Latres, Carla J Greenbaum, Maria L Oyaski, Colin M Dayan, Helen Martina Colhoun, John M Lachin, Jay S Skyler, Michael R Rickels, Simi T Ahmed, Sanjoy Dutta, Kevan C Herold, Marjana Marinac
Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes. Diabetes 73 (6) (2024)
Michael J Haller, David Cuthbertson, Brian N Bundy, Mark A Atkinson, Wayne Moore, Michael J Haller, William E Russell, Stephen E Gitelman, Kevan C Herold, Maria J Redondo, Emily K Sims, Diane K Wherrett, Antoinette Moran, Alberto Pugliese, Peter A Gottlieb, Jay M Sosenko, Heba M Ismail, null null
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials. Diabetes care 47 (6) (2024)
Kevan C Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M Brusko, Lucy Sarah Kate Walker
The immunology of type 1 diabetes. Nature reviews. Immunology (2024)
Christine Bender, Alice E Wiedeman, Alex Hu, Alyssa Ylescupidez, William K Sietsema, Kevan C Herold, Kurt J Griffin, Stephen E Gitelman, Sarah Alice Long, null null, null null
A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes. Science translational medicine 16 (746) (2024)
Kevan C Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M Brusko, Lucy Sarah Kate Walker
The immunology of type 1 diabetes. Nature reviews. Immunology 24 (6) (2024)
Michael J Haller, David Cuthbertson, Brian N Bundy, Mark A Atkinson, Wayne Moore, Michael J Haller, William E Russell, Stephen E Gitelman, Kevan C Herold, Maria J Redondo, Emily K Sims, Diane K Wherrett, Antoinette Moran, Alberto Pugliese, Peter A Gottlieb, Jay M Sosenko, Heba M Ismail, null null
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials. Diabetes care 47 (6) (2024)
Kevan C Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M Brusko, Lucy Sarah Kate Walker
The immunology of type 1 diabetes. Nature reviews. Immunology 24 (6) (2024)
Christine Bender, Alice E Wiedeman, Alex Hu, Alyssa Ylescupidez, William K Sietsema, Kevan C Herold, Kurt J Griffin, Stephen E Gitelman, Sarah Alice Long, null null, null null
A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes. Science translational medicine 16 (746) (2024)
Christine Bender, Alice E Wiedeman, Alex Hu, Alyssa Ylescupidez, William K Sietsema, Kevan C Herold, Kurt J Griffin, Stephen E Gitelman, Sarah Alice Long, null null, null null
A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes. Science translational medicine 16 (746) (2024)
Michael J Haller, David Cuthbertson, Brian N Bundy, Mark A Atkinson, Wayne Moore, Michael J Haller, William E Russell, Stephen E Gitelman, Kevan C Herold, Maria J Redondo, Emily K Sims, Diane K Wherrett, Antoinette Moran, Alberto Pugliese, Peter A Gottlieb, Jay M Sosenko, Heba M Ismail, null null
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials. Diabetes care (2024)
Kevan C Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M Brusko, Lucy Sarah Kate Walker
The immunology of type 1 diabetes. Nature reviews. Immunology (2024)
Kevan C Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M Brusko, Lucy Sarah Kate Walker
The immunology of type 1 diabetes. Nature reviews. Immunology (2024)
Quin Yuhui Xie, Sean Oh, Anthony Wong, Christopher Yau, Kevan C Herold, Jayne S Danska
Immune responses to gut bacteria associated with time to diagnosis and clinical response to T cell-directed therapy for type 1 diabetes prevention. Science translational medicine 15 (719) (2023)
Darrell M Wilson, Susan L Pietropaolo, Maria Acevedo-Calado, Shuai Huang, Destiny Anyaiwe, David Scheinker, Andrea K Steck, Madhuri M Vasudevan, Siripoom V McKay, Jennifer L Sherr, Kevan C Herold, Jessica L Dunne, Carla J Greenbaum, Sandra M Lord, Michael J Haller, Desmond A Schatz, Mark A Atkinson, Patrick W Nelson, Massimo Pietropaolo, null null
CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study. Diabetes care 46 (3) (2023)
William E Russell, Daniel J Moore, Kevan C Herold
Response to Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005-1013. Diabetes care 46 (11) (2023)
Chantal Mathieu, Alice E Wiedeman, Karen Cerosaletti, Sarah Alice Long, Elisavet Serti, Laura G Cooney, Joan Vermeiren, Silvia Caluwaerts, Karolien Van Huynegem, Lothar Steidler, Sven Blomme, Pieter Rottiers, Gerald T Nepom, Kevan C Herold, null null
A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab. Diabetologia (2023)
Ingrid M Libman, Polly J Bingley, Dorothy Becker, Jane H Buckner, Linda A DiMeglio, Stephen E Gitelman, Carla J Greenbaum, Michael J Haller, Heba M Ismail, Jeffrey Krischer, Wayne V Moore, Antoinette M Moran, Andrew B Muir, Vana Raman, Andrea K Steck, Frederico G S Toledo, John M Wentworth, Diane K Wherrett, Perrin C White, Lu You, Kevan C Herold, null null
Hydroxychloroquine in Stage 1 Type 1 Diabetes. Diabetes care (2023)
Jay M Sosenko, David Cuthbertson, Emily K Sims, Heba M Ismail, Brandon M Nathan, Michael J Haller, Mark A Atkinson, Carmella Evans-Molina, Kevan C Herold, Jay S Skyler, Maria Jose Redondo, null null
Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies. Diabetes care (2023)
Darrell M Wilson, Susan L Pietropaolo, Maria Acevedo-Calado, Shuai Huang, Destiny Anyaiwe, David Scheinker, Andrea K Steck, Madhuri M Vasudevan, Siripoom V McKay, Jennifer L Sherr, Kevan C Herold, Jessica L Dunne, Carla J Greenbaum, Sandra M Lord, Michael J Haller, Desmond A Schatz, Mark A Atkinson, Patrick W Nelson, Massimo Pietropaolo, null null
CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study. Diabetes care (2023)
Kevin Dell'Aquila, Jeylin Lee, Stephen H Wang, Tharun T Alamuri, Rebecca Jennings, Helen Tang, Sandhya Mahesh, Taylor Jan Leong, Roman Fleysher, Erin M Henninger, Sudhakar Veeraraghavan, Parsa Mirhaji, Wei Hou, Kevan C Herold, Timothy Q Duong
Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID-19 patients: Comparison with influenza and pre-pandemic data. Diabetes, obesity & metabolism (2023)
William E Russell, Brian N Bundy, Mark S Anderson, Laura A Cooney, Stephen E Gitelman, Robin S Goland, Peter A Gottlieb, Carla J Greenbaum, Michael J Haller, Jeffrey P Krischer, Ingrid M Libman, Carla J Greenbaum, Sarah Alice Long, Sandra M Lord, Daniel J Moore, Wayne V Moore, Antoinette M Moran, Andrew B Muir, Philip Raskin, Jay S Skyler, John M Wentworth, Diane K Wherrett, Darrell M Wilson, Anette-Gabriele Ziegler, Kevan C Herold, null null
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes care (2023)
Darrell M Wilson, Susan L Pietropaolo, Maria Acevedo-Calado, Shuai Huang, Destiny Anyaiwe, David Scheinker, Andrea K Steck, Madhuri M Vasudevan, Siripoom V McKay, Jennifer L Sherr, Kevan C Herold, Jessica L Dunne, Carla J Greenbaum, Sandra M Lord, Michael J Haller, Desmond A Schatz, Mark A Atkinson, Patrick W Nelson, Massimo Pietropaolo, null null
CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study. Diabetes care 46 (3) (2023)
Darrell M Wilson, Susan L Pietropaolo, Maria Acevedo-Calado, Shuai Huang, Destiny Anyaiwe, David Scheinker, Andrea K Steck, Madhuri M Vasudevan, Siripoom V McKay, Jennifer L Sherr, Kevan C Herold, Jessica L Dunne, Carla J Greenbaum, Sandra M Lord, Michael J Haller, Desmond A Schatz, Mark A Atkinson, Patrick W Nelson, Massimo Pietropaolo, null null
CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study. Diabetes care 46 (3) (2023)
Darrell M Wilson, Susan L Pietropaolo, Maria Acevedo-Calado, Shuai Huang, Destiny Anyaiwe, David Scheinker, Andrea K Steck, Madhuri M Vasudevan, Siripoom V McKay, Jennifer L Sherr, Kevan C Herold, Jessica L Dunne, Carla J Greenbaum, Sandra M Lord, Michael J Haller, Desmond A Schatz, Mark A Atkinson, Patrick W Nelson, Massimo Pietropaolo, null null
CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study. Diabetes care 46 (3) (2023)
Emily K Sims, Rachel E J Besser, Colin Dayan, Cristy Geno Rasmussen, Carla J Greenbaum, Kurt J Griffin, William A Hagopian, Olli H Laitinen, Anna E Long, Frank Martin, Chantal Mathieu, Marian Rewers, Andrea K Steck, John M Wentworth, Stephen S Rich, Olga Kordonouri, Anette-Gabriele Ziegler, Kevan C Herold, null null
Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective. Diabetes 71 (4) (2022)
Roberto Mallone, Clémentine Halliez, Jinxiu Rui, Kevan C Herold
The β-Cell in Type 1 Diabetes Pathogenesis: A Victim of Circumstances or an Instigator of Tragic Events? Diabetes 71 (8) (2022)
Moufida Ben Nasr, Francesca D'Addio, Laura Montefusco, Vera Usuelli, Cristian Loretelli, Antonio Rossi, Ida Pastore, Ahmed Abdelsalam, Anna Maestroni, Marco Dell'Acqua, Elio Ippolito, Emma Assi, Andy Joe Seelam, Roberta Maria Fiorina, Enrica Chebat, Paola Morpurgo, Maria Elena Lunati, Andrea Mario Bolla, Reza Abdi, Joseph V Bonventre, Stefano Rusconi, Agostino Riva, Domenico Corradi, Pierachille Santus, Pamela Clark, Manuela Nebuloni, Gabriella Baldi, Giovanna Finzi, Franco Folli, Gian Vincenzo Zuccotti, Massimo Galli, Kevan C Herold, Paolo Fiorina
Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets. Diabetes 71 (7) (2022)
Michelle So, Cate Speake, Andrea K Steck, Markus Lundgren, Peter G Colman, Jerry P Palmer, Kevan C Herold, Carla J Greenbaum
Advances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count. Endocrine reviews 42 (5) (2022)
Randy L Anderson, Linda A DiMeglio, Adrian P Mander, Colin M Dayan, Carla J Greenbaum, Kevan C Herold, Marjana Marinac, Simi T Ahmed
Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes care 45 (10) (2022)
Mei-Ling Yang, Sheryl Horstman, Renelle Gee, Perrin Guyer, Tukiet T Lam, Jean Kanyo, Ana Luisa Perdigoto, Cate Speake, Carla J Greenbaum, Aïsha Callebaut, Lut Overbergh, Richard G Kibbey, Kevan C Herold, Eddie A James, Mark J Mamula
Citrullination of glucokinase is linked to autoimmune diabetes. Nature communications 13 (1) (2022)
Emily K Sims, Brian N Bundy, Kenneth Stier, Elisavet Serti, Noha Lim, Sarah Alice Long, Susan M Geyer, Antoinette M Moran, Carla J Greenbaum, Carmella Evans-Molina, Kevan C Herold, null null
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals. Science translational medicine 13 (583) (2021)
Jinxiu Rui, Songyan Deng, Ana Luisa Perdigoto, Gerald Ponath, Romy Kursawe, Nathan Lawlor, Tomokazu S Sumida, Maya Levine-Ritterman, Michael L Stitzel, David Pitt, Jun Lu, Kevan C Herold
Tet2 Controls the Responses of β cells to Inflammation in Autoimmune Diabetes. Nature communications 12 (1) (2021)
Jeffrey A Bluestone, Jane H Buckner, Kevan C Herold
Immunotherapy: Building a bridge to a cure for type 1 diabetes. Science (New York, N.Y.) 373 (6554) (2021)
James C Reed, Paula Preston-Hurlburt, William Philbrick, Gabriel Betancur, Maria Korah, Carrie Lucas, Kevan C Herold
The receptor for advanced glycation endproducts (RAGE) modulates T cell signaling. PloS one 15 (9) (2020)
Kevan C Herold, Jesse Reynolds, James Dziura, David Baidal, Jason Gaglia, Stephen E Gitelman, Peter A Gottlieb, Jennifer Marks, Louis H Philipson, Rodica Pop-Busui, Ruth S Weinstock
Exenatide extended release in patients with type 1 diabetes with and without residual insulin production. Diabetes, obesity & metabolism 22 (11) (2020)
Simi Ahmed, Karen Cerosaletti, Eddie A James, Sarah Alice Long, Stuart Mannering, Cate Speake, Maki Nakayama, Timothy Tree, Bart O Roep, Kevan C Herold, Todd M Brusko
Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent Advances. Diabetes 68 (7) (2020)
Jay M Sosenko, Jay S Skyler, Kevan C Herold, Desmond A Schatz, Michael J Haller, Alberto Pugliese, Mario Cleves, Susan Geyer, Lisa E Rafkin, Della Matheson, Jerry P Palmer, null null
Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials. Diabetes 69 (8) (2020)
Carl A Pierce, Paula Preston-Hurlburt, Yile Dai, Clare Burn Aschner, Natalia Cheshenko, Benjamin T Galen, Scott J Garforth, Natalia G Herrera, Rohit K Jangra, Nicholas C Morano, Erika P Orner, Sharlene Sy, Kartik Chandran, James D Dziura, Steven C Almo, Aaron M Ring, Marla J Keller, Kevan C Herold, Betsy C Herold
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Science translational medicine 12 (564) (2020)
Michael J Haller, Sarah Alice Long, J Lori Blanchfield, Desmond A Schatz, Jay S Skyler, Jeffrey P Krischer, Brian N Bundy, Susan M Geyer, Megan V Warnock, Jessica L Miller, Mark A Atkinson, Dorothy J Becker, David A Baidal, Linda A DiMeglio, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Kevan C Herold, Jennifer B Marks, Antoinette M Moran, Henry Rodriguez, William E Russell, Darrell M Wilson, Carla J Greenbaum, null null
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data. Diabetes 68 (6) (2019)
Manuela Battaglia, Simi Ahmed, Mark S Anderson, Mark A Atkinson, Dorothy Becker, Polly J Bingley, Emanuele Bosi, Todd M Brusko, Linda A DiMeglio, Carmella Evans-Molina, Stephen E Gitelman, Carla J Greenbaum, Peter A Gottlieb, Kevan C Herold, Martin J Hessner, Olli H Laitinen, Michael J Haller, Jeffrey P Krischer, Sarah Alice Long, Markus Lundgren, Eoin F McKinney, Noel G Morgan, Richard D Oram, Tomi Pastinen, Michael C Peters, Alessandra Petrelli, Xiaoning Qian, Maria Jose Redondo, Bart O Roep, Desmond Schatz, David Skibinski, Mark Peakman
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes. Diabetes care 43 (1) (2019)
Vincent Poitout, Leslie S Satin, Steven E Kahn, Doris A Stoffers, Piero Marchetti, Maureen Gannon, C Bruce Verchere, Kevan C Herold, Martin G Myers, Sally M Marshall
A Call for Improved Reporting of Human Islet Characteristics in Research Articles. Diabetes 68 (2) (2018)
Carla J Greenbaum, Cate Speake, Jeffrey P Krischer, Jane Buckner, Peter A Gottlieb, Desmond A Schatz, Kevan C Herold, Mark A Atkinson
Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes-The TrialNet Experience. Diabetes 67 (7) (2018)
Angeliki M Stamatouli, Zoe Quandt, Ana Luisa Perdigoto, Pamela L Clark, Harriet Kluger, Sarah A Weiss, Scott Gettinger, Mario Sznol, Arabella Young, Robert Rushakoff, James Lee, Jeffrey A Bluestone, Mark Anderson, Kevan C Herold
Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors. Diabetes 67 (8) (2018)
Michael J Haller, Desmond A Schatz, Jay S Skyler, Jeffrey P Krischer, Brian N Bundy, Jessica L Miller, Mark A Atkinson, Dorothy J Becker, David Baidal, Linda A DiMeglio, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Kevan C Herold, Jennifer B Marks, Antoinette M Moran, Henry Rodriguez, William Russell, Darrell M Wilson, Carla J Greenbaum, null null
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes. Diabetes care 41 (9) (2018)
Sean P Durning, Paula Preston-Hurlburt, Paul R Clark, Ding Xu, Kevan C Herold, null null
The Receptor for Advanced Glycation Endproducts Drives T Cell Survival and Inflammation in Type 1 Diabetes Mellitus. Journal of immunology (Baltimore, Md. : 1950) 197 (8) (2016)
Justin W Garyu, Mohamed Uduman, Alex Stewart, Jinxiu Rui, Songyan Deng, Jared Shenson, Matt M Staron, Susan M Kaech, Steven H Kleinstein, Kevan C Herold
Characterization of Diabetogenic CD8+ T Cells: IMMUNE THERAPY WITH METABOLIC BLOCKADE. The Journal of biological chemistry 291 (21) (2016)

Kevan C Herold.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kevan C Herold